Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing: Collaboration is a key component to achieving long-term success with genetic medicines.

The article focuses on the recent Nobel Prize in Physiology or Medicine awarded to Katalin Karikó and Drew Weissman for their research on RNA, highlighting the advancements in genetic medicine, challenges in non-viral delivery systems, and the importance of collaboration and investment in manufacturing to realize the potential of novel genetic therapies.